Fibrinogen Blood Test

What Does This Test Measure?

Fibrinogen is a soluble plasma protein (clotting factor I) produced by the liver. It is the final step in the coagulation cascade, thrombin converts fibrinogen to insoluble fibrin, which forms the mesh of a blood clot. Fibrinogen is also an acute phase reactant that rises with inflammation.

Why Your Doctor Ordered This Test

Fibrinogen testing is ordered primarily when a patient has unexplained bleeding or bruising, or when clotting events occur without a clear cause. Because fibrinogen is the precursor to fibrin, the structural protein of a blood clot, its measurement is central to evaluating the coagulation system. A physician may suspect a fibrinogen deficiency if routine coagulation tests like PT and aPTT are prolonged and the platelet count is normal, but bleeding persists. In such cases, a low fibrinogen level confirms hypofibrinogenemia. In the acute setting, fibrinogen is monitored during suspected disseminated intravascular coagulation (DIC), a condition where widespread microthrombi form and consume clotting factors, including fibrinogen, leading to a dangerously low level below 100 mg/dL. Obstetric complications, severe sepsis, and certain cancers can trigger DIC.

Doctors also use fibrinogen to gauge systemic inflammation and cardiovascular risk. As an acute phase reactant, fibrinogen rises in response to inflammatory cytokines, making it a marker for chronic inflammatory conditions like rheumatoid arthritis, inflammatory bowel disease, and chronic infections. Furthermore, elevated fibrinogen is an independent risk factor for arterial thrombosis; studies show that each standard deviation increase in fibrinogen raises the risk of myocardial infarction and ischemic stroke by 20-30%. Thus, a fibrinogen test may be part of a cardiovascular risk panel, especially in patients with a family history of early heart disease or those with metabolic syndrome. In patients undergoing surgery or with major trauma, serial fibrinogen measurements guide cryoprecipitate or fibrinogen concentrate replacement to maintain hemostasis, with a target above 150–200 mg/dL in bleeding patients.

What High Fibrinogen Means

High fibrinogen: inflammation (acute phase reactant, infection, autoimmune disease, malignancy), pregnancy (estrogen-driven), cardiovascular disease (elevated fibrinogen is an independent risk factor for MI and stroke, it promotes clot formation and increases blood viscosity), smoking, obesity, and diabetes. High fibrinogen levels increase thrombotic risk.

What Low Fibrinogen Means

Low fibrinogen: decreased production (advanced liver disease, the liver produces fibrinogen), increased consumption (DIC, widespread clotting consumes fibrinogen; this is a poor prognostic finding), massive transfusion (dilution), and rare inherited disorders (afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia; abnormal fibrinogen that may not function).

How to Prepare and What Affects the Result

Most fibrinogen tests do not require fasting, but if the test is part of a comprehensive lipid panel or cardiovascular risk assessment, a 9- to 12-hour fast is common to avoid lipemic interference in other assays. More importantly, fibrinogen is an acute phase reactant, so recent illness, infection, surgery, or even a minor injury can falsely elevate the result. To obtain a baseline value, the blood draw should be postponed until 2–3 weeks after any acute inflammatory episode. Smoking can transiently raise fibrinogen by 10–20%, so refrain from smoking for at least 30 minutes before the draw. Strenuous physical activity and emotional stress also temporarily increase fibrinogen; sitting quietly for 15 minutes prior to venipuncture is recommended.

Several medications influence fibrinogen levels. Estrogen-containing contraceptives, hormone replacement therapy, and pregnancy raise fibrinogen by 20–40% due to increased hepatic synthesis. Conversely, anabolic steroids and certain fibrate drugs (such as bezafibrate) lower fibrinogen. Statins may also modestly reduce fibrinogen independent of lipid lowering. Blood should be collected into a 3.2% sodium citrate tube (light blue top) and mixed gently to prevent clotting activation. The sample must be centrifuged within 1 hour to achieve platelet-poor plasma (platelets <10,000/µL) and assayed within 4 hours, or the plasma should be frozen at -20°C or colder until testing. Even trace amounts of hemolysis or platelet contamination can activate the sample, yielding falsely low fibrinogen due to consumption or falsely high from platelet-derived fibrinogen fragments; therefore, a clean, atraumatic venipuncture and proper processing are critical.

Common Misinterpretations

One common misinterpretation is attributing a low fibrinogen level solely to reduced liver production without considering consumption. In patients with acute bleeding or sepsis, a drop in fibrinogen often signals DIC, not liver failure, especially when accompanied by elevated D-dimer and falling platelet counts. Missing this distinction can delay life-saving interventions like replacing clotting factors and treating the underlying cause. Another pitfall is using a single fibrinogen value to rule out DIC: the test can be normal or even elevated early in DIC because the acute phase response may initially compensate for consumption. Therefore, a trend of decreasing fibrinogen over hours is more informative than a single point.

Fibrinogen is also misread when clinicians rely on it as a standalone cardiovascular risk marker. While epidemiologic data link high fibrinogen with myocardial infarction and stroke, the effect is partly confounded by smoking, inflammation, and metabolic factors. A moderately elevated fibrinogen in a smoker or person with arthritis does not automatically warrant aggressive anticoagulation; it indicates the need to address underlying risk factors. Conversely, a low functional fibrinogen result in a patient with a bleeding history may be mistaken as a mild quantitative deficiency when it could be a qualitative defect (dysfibrinogenemia). In dysfibrinogenemia, the Clauss assay (functional) is low, but immunologic assays show normal fibrinogen antigen levels. This discrepancy can be overlooked if only a functional test is ordered, leading to incorrect categorization and management. Also, elevated fibrinogen due to pregnancy or estrogen therapy is physiological and should not be interpreted as a disease state; after delivery or cessation, levels normalize. Finally, fibrinogen results from heparin-contaminated samples or traumatic venipuncture can be falsely lowered by in vitro activation, mimicking a consumption state.

Frequently Asked Questions

What does a high fibrinogen level mean?

A high fibrinogen level usually indicates inflammation or an acute phase response. Conditions like infections, autoimmune disorders, cancer, and tissue injury raise fibrinogen. Pregnancy and estrogen medications also increase it. Elevated fibrinogen increases blood viscosity and clotting tendency, independently raising the risk of myocardial infarction and ischemic stroke. A value above 400 mg/dL prompts evaluation for chronic inflammatory diseases and cardiovascular risk assessment, often alongside hs-CRP and lipid levels.

What causes low fibrinogen in the blood?

Low fibrinogen arises from reduced liver production (cirrhosis, severe hepatitis), increased consumption (disseminated intravascular coagulation, major trauma, extensive thrombosis), massive blood transfusion (dilutional effect), or rare inherited disorders such as afibrinogenemia and hypofibrinogenemia. Clinically significant bleeding risk emerges when fibrinogen drops below 100 mg/dL, with spontaneous hemorrhage possible below 50 mg/dL. In DIC, a falling fibrinogen along with elevated D-dimer confirms a consumptive coagulopathy that requires urgent treatment of the underlying trigger.

How is fibrinogen related to D-dimer and DIC?

Fibrinogen and D-dimer are key markers in diagnosing disseminated intravascular coagulation (DIC). In DIC, widespread microclot formation consumes fibrinogen, causing its level to drop, while fibrinolysis breaks down clots, releasing D-dimer fragments. A falling fibrinogen with a steeply rising D-dimer and thrombocytopenia confirms DIC. Early DIC may show a normal or elevated fibrinogen due to an acute phase response, so trending serial measurements is critical for accurate interpretation.

Can fibrinogen levels predict heart disease?

Elevated fibrinogen is an independent risk factor for coronary artery disease, myocardial infarction, and ischemic stroke. Epidemiological studies indicate that each gram per liter increase in fibrinogen raises cardiovascular event risk by roughly 20–30%. However, fibrinogen is also influenced by smoking, inflammation, and obesity, so it is not used as a standalone prediction tool. It is best interpreted alongside hs-CRP, lipid profiles, and clinical risk factors to refine cardiovascular risk stratification.

What is the difference between functional and antigenic fibrinogen tests?

The functional fibrinogen assay (Clauss method) measures how quickly fibrin clot forms after adding thrombin, reflecting the protein’s activity. This test is low in quantitative deficiencies and dysfibrinogenemias where the fibrinogen is present but dysfunctional. The antigenic assay uses immunologic methods to measure fibrinogen protein mass regardless of function. In dysfibrinogenemia, functional fibrinogen is low while antigenic levels remain normal. Clinicians use the functional test for bleeding assessment and the antigenic test to detect dysfunctional variants.

Related Markers: Read Together for Full Context

BloodWorker reads lab values together, not in isolation. These related markers provide essential context for interpreting your Fibrinogen result: